Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.

Raloxifene treatment in Maternal Immune Activation model of Schizophrenia

Studying the molecular basis of raloxifene (a SERM) modulation of dopamine signalling in schizophrenia, which uses a maternal immune activation rodent model of schizophrenia to better understand how raloxifene brings about its effects.